Edges in Network
Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
Node | MAP3K11 |
Upstream (Parents) |
---|
(<<) ADAM10 → MAP3K11 |
(<<) HMGCR → MAP3K11 |
(<<) IDI1 → MAP3K11 |
(<<) INF2 → MAP3K11 |
(<<) LYPLA2 → MAP3K11 |
(<<) MAPK1 → MAP3K11 |
(<<) POLR1B → MAP3K11 |
(<<) RHOA → MAP3K11 |
(<<) RNF111 → MAP3K11 |
(<<) SET → MAP3K11 |
(<<) SF3A2 → MAP3K11 |
(<<) SLC25A32 → MAP3K11 |
(<<) STAM2 → MAP3K11 |
(<<) TCOF1 → MAP3K11 |
(<<) TSPAN3 → MAP3K11 |
(<<) UBQLN2 → MAP3K11 |
Downstream (Children) |
---|
MAP3K11 → ADAM9 (>>) |
MAP3K11 → ATP2A2 (>>) |
MAP3K11 → COL13A1 (>>) |
MAP3K11 → CXADR (>>) |
MAP3K11 → DYNLL1 (>>) |
MAP3K11 → FZD8 (>>) |
MAP3K11 → HPS6 (>>) |
MAP3K11 → ITPR1 (>>) |
MAP3K11 → KCNN4 (>>) |
MAP3K11 → KHDRBS3 (>>) |
MAP3K11 → MAP3K14 (>>) |
MAP3K11 → MAP3K3 (>>) |
MAP3K11 → NDST1 (>>) |
MAP3K11 → NFKBIA (>>) |
MAP3K11 → PLA2G6 (>>) |
MAP3K11 → PLCH2 (>>) |
MAP3K11 → PPP3CC (>>) |
MAP3K11 → RPS6KA1 (>>) |
MAP3K11 → SHC2 (>>) |
MAP3K11 → SMO (>>) |
MAP3K11 → TCEAL1 (>>) |
MAP3K11 → TRAF1 (>>) |
MAP3K11 → UBE2J1 (>>) |